Document Detail


Regenerative inductive therapy based on DDS technology of protein and gene.
MedLine Citation:
PMID:  17062395     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recent development of biomedical engineering including biomaterials and drug delivery system (DDS) as well as basic biology and medicine has enabled cells to induce regeneration repairing of defective tissues as well as substitute the biological functions of damaged organs. For successful tissue regeneration, it is undoubtedly indispensable to give cells a local environment which allows cells to efficiently promote their proliferation and differentiation and consequently induce cell-based tissue regeneration. Tissue engineering is one of the biomedical forms to create this regeneration environment of cells. The tissue and organ repairing based on their regeneration induction has been realized by combining cells with the tissue engineering technology or methodology in a surgical or internally medical manner. This paper overviews the present status and future direction of tissue engineering for regenerative inductive therapy, briefly explaining the key technology of tissue engineering, especially DDS of growth factor and gene.
Authors:
Yasuhiko Tabata
Related Documents :
11976905 - Visualisation of hyaluronan and hyaluronan-binding proteins within ovine vertebral cart...
19326965 - Organization of extracellular matrix fibers within polyglycolic acid-polylactic acid sc...
20547385 - Effect of microwell chip structure on cell microsphere production of various animal cells.
18192355 - Do cells sense stress or strain? measurement of cellular orientation can provide a clue.
19206525 - Influence of size, surface, cell line, and kinetic properties on the specific binding o...
21161615 - Alterations of the b-cell response by hiv-1 replication.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of drug targeting     Volume:  14     ISSN:  1061-186X     ISO Abbreviation:  J Drug Target     Publication Date:  2006  
Date Detail:
Created Date:  2006-10-25     Completed Date:  2007-02-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9312476     Medline TA:  J Drug Target     Country:  England    
Other Details:
Languages:  eng     Pagination:  483-95     Citation Subset:  IM    
Affiliation:
Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8507, Japan. yasuhiko@frontier.kyoto-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Drug Delivery Systems / methods*
Growth Substances / administration & dosage*,  genetics,  physiology
Humans
Models, Biological
Regeneration / drug effects*,  physiology
Regenerative Medicine / methods*
Technology, Pharmaceutical / methods,  trends
Tissue Engineering / methods
Chemical
Reg. No./Substance:
0/Growth Substances

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Corneal epithelial stem cell delivery using cell sheet engineering: not lost in transplantation.
Next Document:  Quantitative structure/activity relationship modelling of pharmacokinetic properties using genetic a...